Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23439259 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)
Condition: Hepatitis C, Chronic
Interventions: Drug: Vaniprevir;   Drug: Pegylated Interferon (Peg-IFN);   Drug: Ribavirin (RBV);   Drug: Placebo (PBO)

Indicates status has not been verified in more than two years